Nutex Health Inc. (NUTX) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Net income in fiscal 2025 was $71M, a net margin of 8.1%; the best year in this period was 2021 with $133M.
Over the twelve months to September 30, 2026, revenue was $797M and net income $165M.
Free cash flow was $246M in fiscal 2025 and positive in 5 of the 10 years shown.
The diluted share count rose 1337% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $797M | $875M | $480M | $248M | $219M | $332M | $274M | $1M | $1M | — | $0 |
| Gross profit | $381M | $444M | $196M | $35M | $15M | $179M | $158M | $535976 | $859356 | -$7315 | $0 |
| Operating income | $311M | $276M | $131M | -$32M | -$407M | $170M | $153M | -$7M | -$840398 | -$6M | -$448595 |
| Net income | $165M | $71M | $52M | -$46M | -$425M | $133M | $106M | -$7M | -$950129 | $582062 | -$7M |
| EPS (diluted) | $23.22 | $10.48 | $9.69 | $-10.39 | $-100.36 | $0.22 | $0.18 | $-1.96 | $-0.56 | $0.84 | $-16.04 |
| R&D | — | — | — | — | — | $285880 | $557257 | $768103 | $545223 | — | — |
| Revenue growth | — | +82.4% | +93.8% | +12.9% | −33.9% | +21.0% | +19954.5% | −0.0% | — | — | −100.0% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $258M | $248M | $23M | $1M | $51M | $173M | $87M | -$4M | -$480049 | -$714623 | -$274223 |
| Capital spending | -$10M | -$3M | -$2M | -$9M | -$15M | -$37M | -$61M | -$84002 | $0 | — | — |
| Free cash flow | $248M | $246M | $21M | -$8M | $36M | $137M | $25M | -$4M | -$480049 | — | — |
| Dividends paid | $86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $56M | $5M | $0 | $0 | — | — | — | — | — | — | — |
| Stock-based pay | — | $108M | -$129743 | — | $189581 | $4M | $3M | $450054 | $155886 | $924326 | $1500 |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $186M | $41M | $22M | $34M | $36M | $26931 | $1M | $119267 | $9449 | $10522 |
| Debt | — | $76M | $74M | $59M | $59M | $89M | $462890 | $640957 | $779779 | $52500 | — |
| Equity | — | $329M | $132M | $61M | $96M | $115M | -$1M | $2M | -$1M | -$997224 | -$6M |
| Total assets | — | $919M | $655M | $398M | $432M | $395M | $169857 | $7M | $449428 | $3M | $510835 |
| Shares (diluted) | 7M | 7M | 5M | 4M | 4M | 593M | 5M | 4M | 2M | 1M | 0M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 47.8% | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% | 39.2% | 62.9% | — | — |
| Operating margin | 39.0% | 31.5% | 27.2% | -12.8% | -185.4% | 51.4% | 55.9% | -504.8% | -61.5% | — | — |
| Net margin | 20.7% | 8.1% | 10.8% | -18.5% | -193.7% | 40.0% | 38.7% | -520.8% | -69.5% | — | — |
| FCF margin | 31.1% | 28.1% | 4.3% | -3.3% | 16.4% | 41.2% | 9.3% | -301.9% | -35.1% | — | — |
| ROIC | — | 50.1% | 54.6% | -23.5% | -206.8% | 83.1% | — | -276.0% | — | — | — |
| ROE | — | 21.5% | 39.3% | -74.5% | -443.1% | 115.7% | -9346.5% | -382.9% | 63.4% | -58.4% | 126.6% |
Frequently asked questions
What is Nutex Health’s annual revenue?
$875M in fiscal 2025 and $797M over the twelve months to September 30, 2026.
How much profit does Nutex Health make?
Net income was $71M in fiscal 2025 (net margin 8.1%).
Is Nutex Health’s revenue growing?
Yes: revenue rose 82.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.